Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Deloitte ranks ‘North America Technology Fast 500’

Deloitte has released its “North America Technology Fast 500,” an annual ranking of the fastest-growing North American companies in the technology, media, telecommunications, life sciences, fintech...

| By Kelley Gipson

Murphy names Azitra ‘Innovator of the Month’

U.S. Senator Chris Murphy (D-Conn.) has named Azitra Inc. in Branford Innovator of the Month. The company currently has 14 employees in Connecticut and will be...

| By Kelley Gipson

UConn teams studying aging, mitochondria

A team of researchers at UConn are working on ways to reverse the effects of aging, as a way to mitigate the severity of a...

| By Kelley Gipson

Manchester’s Woven prepares device for U.S. sale

Woven Orthopedic Technologies, based in Manchester,  is bringing its surgical screw sleeves, in development since 2013, to the U.S. market. The FDA granted a so-called...

| By Kelley Gipson

Bristol Myers Squibb acquires MyoKardia

Bristol-Myers Squibb has successfully completed its acquisition of MyoKardia in an all cash transaction for approximately $13.1 billion. “We are excited to welcome MyoKardia colleagues...

| By Kelley Gipson

Guilford’s Homodeus ramps up for COVID home test

A nasal swab test from Guilford’s Homodeus is showing progress in trials. “So far, the clinical studies have been 100% accurate both in terms detecting positives...

| By Kelley Gipson

Intensity reports favorable data re solid tumor drug

Intensity Therapeutics has reported efficacy and safety data from the ongoing Phase 1/2 clinical study of INT230-6, the Company’s lead product candidate. “The preliminary data generated...

| By Kelley Gipson

AstraZeneca reports ‘highly effective’ vaccine

The drugmaker AstraZeneca announced on Monday that an early analysis of some of its late-stage clinical trials, conducted in the United Kingdom and Brazil, showed...

| By Kelley Gipson

Dr. Carine Boustany promoted at Boehringer Ingelheim

Dr. Carine Boustany has been named Global Head, Development Science and Head, Development Site U.S. at Boehringer Ingelheim, beginning January 1, 2021. Dr. Boustany sits on...